Follow
Annabelle (Mimi) M. Belcher
Annabelle (Mimi) M. Belcher
University of Maryland School of Medicine
Verified email at som.umaryland.edu - Homepage
Title
Cited by
Cited by
Year
Personality traits and vulnerability or resilience to substance use disorders
AM Belcher, ND Volkow, FG Moeller, S Ferré
Trends in cognitive sciences 18 (4), 211-217, 2014
2202014
Large-scale brain networks in the awake, truly resting marmoset monkey
AM Belcher, CC Yen, H Stepp, H Gu, H Lu, Y Yang, AC Silva, EA Stein
Journal of neuroscience 33 (42), 16796-16804, 2013
1522013
Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine-or d-amphetamine-induced neurotoxicity
AM Belcher, SJ O'Dell, JF Marshall
Neuropsychopharmacology 30 (11), 2026-2034, 2005
1312005
Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine
A Izquierdo, AM Belcher, L Scott, VA Cazares, J Chen, SJ O'dell, ...
Neuropsychopharmacology 35 (2), 505-514, 2010
1192010
The influence of sex versus sex-related traits on long-term memory for gist and detail from an emotional story
L Cahill, L Gorski, A Belcher, Q Huynh
Consciousness and cognition 13 (2), 391-400, 2004
1032004
Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens
AM Belcher, EM Feinstein, SJ O'dell, JF Marshall
Neuropsychopharmacology 33 (6), 1453-1463, 2008
982008
Methamphetamine‐induced neural and cognitive changes in rodents
JF Marshall, AM Belcher, EM Feinstein, SJ O'Dell
Addiction 102, 61-69, 2007
872007
The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating
D Feifel, PD Shilling, AM Belcher
European Neuropsychopharmacology 22 (5), 374-378, 2012
522012
A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition
AM Belcher, SJ O’Dell, JF Marshall
Behavioural brain research 170 (1), 167-172, 2006
482006
Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids
NS Cai, C Quiroz, J Bonaventura, A Bonifazi, TO Cole, J Purks, AS Billing, ...
The Journal of clinical investigation 129 (7), 2730-2744, 2019
472019
Patient satisfaction with medications for opioid use disorder treatment via telemedicine: brief literature review and development of a new assessment
TO Cole, D Robinson, A Kelley-Freeman, D Gandhi, AD Greenblatt, ...
Frontiers in public health 8, 557275, 2021
422021
Effects of hippocampal lesions on the monkey's ability to learn large sets of object‐place associations
AM Belcher, RA Harrington, L Malkova, M Mishkin
Hippocampus 16 (4), 361-367, 2006
362006
Neurodevelopmental precursors and consequences of substance use during adolescence: Promises and pitfalls of longitudinal neuroimaging strategies
DH Fishbein, EJ Rose, VL Darcey, AM Belcher, JW VanMeter
Frontiers in Human Neuroscience 10, 296, 2016
342016
Role of placebo effects in pain and neuropsychiatric disorders
AM Belcher, S Ferré, PE Martinez, L Colloca
Progress in Neuro-Psychopharmacology and Biological Psychiatry 87, 298-306, 2018
302018
Mobile telemedicine for buprenorphine treatment in rural populations with opioid use disorder
E Weintraub, C Seneviratne, J Anane, K Coble, J Magidson, S Kattakuzhy, ...
JAMA network open 4 (8), e2118487-e2118487, 2021
282021
Outcomes for patients receiving telemedicine-delivered medication-based treatment for opioid use disorder: a retrospective chart review
E Weintraub, AD Greenblatt, J Chang, CJ Welsh, AP Berthiaume, ...
Heroin addiction and related clinical problems 23 (2), 5, 2021
272021
Functional connectivity hubs and networks in the awake marmoset brain
AM Belcher, CCC Yen, L Notardonato, TJ Ross, ND Volkow, Y Yang, ...
Frontiers in Integrative Neuroscience 10, 9, 2016
272016
“In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention
MS Anvari, MB Kleinman, EC Massey, VD Bradley, JW Felton, AM Belcher, ...
Journal of substance abuse treatment 138, 108721, 2022
262022
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
AM Belcher, TO Cole, AD Greenblatt, SW Hoag, DH Epstein, M Wagner, ...
BMJ open 9 (6), e026604, 2019
252019
Neurolaw
A Belcher, W Sinnott‐Armstrong
Wiley Interdisciplinary Reviews: Cognitive Science 1 (1), 18-22, 2010
232010
The system can't perform the operation now. Try again later.
Articles 1–20